Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
110 milligram (mg) fampridine-SR (4-aminopyridine, 4-AP)----1件: 13 💬
215 mg fampridine-SR (4-aminopyridine, 4-AP)----1件: 13 💬
320 mg fampridine-SR (4-aminopyridine, 4-AP)----1件: 13 💬
4BIIB041 (fampridine)----1件: 13 💬
5BIIB041 (Fampridine-SR)----1件: 13 💬
6BIIB041 (PR Fampridine)----1件: 13 💬
7Dalfampridine
(Fampridine)		1件: Dalfampridine (Fampridine)1件: Dalfampridine (Fampridine) 💬 7件: KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬 		5件: Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 4, 13 💬
8Dalfampridine 10 MG [Ampyra]
(Fampridine)		1件: Dalfampridine (Fampridine)1件: Dalfampridine (Fampridine) 💬 7件: KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬 		5件: Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
9Dalfampridine ER
(Fampridine)		1件: Dalfampridine (Fampridine)1件: Dalfampridine (Fampridine) 💬 7件: KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬 		5件: Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
10Dalfampridine ER, 10 Mg Oral Tablet, Extended Release
(Fampridine)		1件: Dalfampridine (Fampridine)1件: Dalfampridine (Fampridine) 💬 7件: KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬 		5件: Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
11Dalfampridine-ER 10mg
(Fampridine)		1件: Dalfampridine (Fampridine)1件: Dalfampridine (Fampridine) 💬 7件: KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬 		5件: Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
12Dalfampridine-ER 5mg
(Fampridine)		1件: Dalfampridine (Fampridine)1件: Dalfampridine (Fampridine) 💬 7件: KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬 		5件: Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
13Extended release fampridine----1件: 13 💬
14FAMPRIDINE----2件: 13, 14 💬
15Fampridine 10 mg prolonged-release tablet (per os)----1件: 18 💬
16Fampridine SR----1件: 13 💬
17Fampridine-SR----1件: 13 💬
18Fampridine-SR b.i.d. (Twice Daily)----1件: 13 💬
19Other: Dalfampridine plus physical therapy
(Fampridine)		1件: Dalfampridine (Fampridine)1件: Dalfampridine (Fampridine) 💬 7件: KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬 		5件: Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
20Other: Withdrawal of dalfampridine-ER 10mg
(Fampridine)		1件: Dalfampridine (Fampridine)1件: Dalfampridine (Fampridine) 💬 7件: KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬 		5件: Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
21Prolonged-release Fampridine----1件: 13 💬
22SR-fampridine----1件: 13 💬
23Sustained-release oral dalfampridine
(Fampridine)		1件: Dalfampridine (Fampridine)1件: Dalfampridine (Fampridine) 💬 7件: KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬 		5件: Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬